TCTMD (@TCTMD) header
TCTMD (@TCTMD) profile picture

TCTMD

@TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at https://xitter.gq/t.co/9j3KOiiahQ

 New York, NY
tctmd.com
Joined May 2009
  • Tweets21K
  • Following6.6K
  • Followers28.3K
8.3KMedia
Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)Photo by TCTMD (@TCTMD)
Early Signs of Vascular, Cardiorespiratory Problems Seen in Regular Vape Users bit.ly/4Bloo52
Image from TCTMD (@TCTMD)
1
515
On-Duty Firefighter Deaths Are Increasingly Cardiac in Nature bit.ly/47HW3s7
Image from TCTMD (@TCTMD)
1
507
Degenerative Mitral Valve Disease Rising Steadily Worldwide With Sharp Sex, Socioeconomic Divides bit.ly/3UBc1Bq
Image from TCTMD (@TCTMD)
1
548
SPYRAL-AFFIRM: Renal Denervation Safe, Effective in Patients Who Are Often Overlooked bit.ly/4sE4zSy
Image from TCTMD (@TCTMD)
3
8
731
Tricuspid Repair Benefits Consistent Across TRIC-I-HF Subgroups bit.ly/48v19It
Image from TCTMD (@TCTMD)
1
6
833
SIMPLAAFY Supports Antithrombotic Monotherapy After LAAO bit.ly/4iUIdJg
SIMPLAAFY Supports Antithrombotic Monotherapy After LAAO

SIMPLAAFY Supports Antithrombotic Monotherapy After LAAO

Accumulating evidence indicates that patients don’t benefit from DAPT after the procedure, Saibal Kar says.

tctmd.com
2
640
As TR Increases in Severity, It Also Becomes More Deadly bit.ly/4kv0VZ4
Image from TCTMD (@TCTMD)
3
628
PROGRESS: TAVI Is Effective, Safe in Moderate AS With At-Risk Features bit.ly/4sEAcv9
Image from TCTMD (@TCTMD)
4
815
Coronary Sinus Reducer Has Little Impact on ANOCA in Sham-Controlled Trial bit.ly/4zpAjxj
Image from TCTMD (@TCTMD)
1
542
That’s a wrap on #TCT2026! You can find all the latest news on TCTMD.com and stay tuned for more coverage coming soon. tctmd.com/TCT2026
484
Want more insights into late-breaking trials from #TCT2026? In this Beyond the Data, Mamas Mamas, Philippe Généreux(@PhilGenereuxMD), and Stephan Windecker discuss the PROGRESS trial outcomes. Watch the full video: bit.ly/47WWnDA
5
6
797
Sirolimus DCB Holds Up Well at 1 Year vs Standard DES in TRANSFORM II bit.ly/4zrTJlj
Image from TCTMD (@TCTMD)
8
13
1,096
Continue learning beyond #TCT2026. Access Impella education, events, and clinical resources: bit.ly/tct2026 #Sponsored
Image from TCTMD (@TCTMD)
3
3
527
CCTA Noninferior to IVUS for PCI Guidance: P4 Trial bit.ly/4jU7JiU
Image from TCTMD (@TCTMD)
1
2
543
TAVI Plus GDMT Suitable for Select Patients With Severe Aortic Regurgitation bit.ly/4edezMF
Image from TCTMD (@TCTMD)
1
490
🔥 Day 3 brought the energy, and #TCT2026 isn’t done yet! From breakthrough science and Live Cases to hands-on learning and unforgettable connections, yesterday delivered moment after moment. 🎥 Relive the highlights, then get ready to make the final day count! 🚀🫀 #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii @MAnisHaider @Rushil_Vasudev
5
1
7
744
At 1 Year, Real-world Agent DCB Outcomes Reassure Despite Patient Complexity bit.ly/3WkNNMf
Image from TCTMD (@TCTMD)
4
8
794

No more items